|
|
Blood, Vol. 111, Issue 2, 566-573, January 15, 2008
Phase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic leukemia or lymphoma
Blood Fox et al.
111: 566
Supplemental materials for: Fox et al
Participating Children’s Oncology Group Institutions Children’s Hospital and Regional Medical Center (Seattle)
Children’s Hospital of Los Angeles
Children’s Hospital of Philadelphia
Indiana University – Riley Children’s Hospital
Johns Hopkins Hospital
Mayo Clinic and Foundation
Primary Children’s Hospital (Utah)
Stanford University Medical Center
St Jude Children’s Research Hospital
Texas Children’s Cancer Center at Baylor College of Medicine
University of California, Los Angeles
University of Michigan
University of Minnesota
|
|
